Adding to library failed Follow podcast failed Unfollow podcast failed Narrated by: On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies
These beneficial effects may be related to the alleviation of GPX4 promoter hypermethylation
Selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) raise levels of important neurotransmitters that are low in some people with ME/CFS
Lillys Phase 3 SUMMIT trial gave either tirzepatide (5 mg, 10 mg or 15 mg) or placebo to 731 adults with HFpEF and obesity, finding that the tirzepatide group
Your body has adjusted well to any digestive issues from Tirzepatide
By removing these patents from the register, Teva effectively dismantled the mechanism for triggering a 30-month stay on those specific grounds, clearing a path for generic competitors to file ANDAs without facing an automatic 2.5-year delay based on device mechanics